Company intelligence / Profile preview

Origin Technologies

Taiwan

Ownership: Private
Development stage: Other

Overview

Develops rapid and accurate molecular detection technologies and IVD kits for prevention, screening, and diagnosis of maternal/child health and genetic diseases.

Therapeutic areas: OtherRare DiseasesWomen's Health
Industry: Molecular Diagnostics

Partnerships

Chinese hospitals (market access and NMPA licensing support)

Beyond the preview

Go deeper on Origin Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Origin Technologies.

Explore the full profile